PHASE-II STUDY OF CONTINUOUS 5-DAY VINBLASTINE INFUSION IN RENAL ADENOCARCINOMA

被引：0
|
作者：
KUEBLER, JP
HOGAN, TF
TRUMP, DL
BRYAN, GT
机构：
[1] W VIRGINIA UNIV,MED CTR,SCH MED,DEPT MED,MORGANTOWN,WV 26506
[2] UNIV WISCONSIN,CTR HLTH SCI,WISCONSIN CLIN CANC CTR,DEPT HUMAN ONCOL,DIV CLIN ONCOL,MADISON,WI 53706
来源：
CANCER TREATMENT REPORTS | 1984年 / 68卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：925 / 926
页数：2
相关论文
共 50 条
  • [21] OXALIPLATIN ACTIVITY AGAINST METASTATIC COLORECTAL-CANCER - A PHASE-II STUDY OF 5-DAY CONTINUOUS VENOUS INFUSION AT CIRCADIAN-RHYTHM MODULATED RATE
    LEVI, F
    PERPOINT, B
    GARUFI, C
    FOCAN, C
    CHOLLET, P
    DEPRESBRUMMER, P
    ZIDANI, R
    BRIENZA, S
    ITZHAKI, M
    IACOBELLI, S
    KUNSTLINGER, F
    GASTIABURU, J
    MISSET, JL
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) : 1280 - 1284
  • [22] 5-DAY CONTINUOUS INFUSION OF 5-FLUOROURACIL FOR ADVANCED COLORECTAL, GASTRIC, AND PANCREATIC ADENOCARCINOMA
    HARTMAN, HA
    KESSINGER, A
    LEMON, HM
    FOLEY, JF
    JOURNAL OF SURGICAL ONCOLOGY, 1979, 11 (03) : 227 - 238
  • [23] PHASE-II TRIAL OF CARBOPLATIN AND VINBLASTINE IN ADENOCARCINOMA OF THE STOMACH
    GINN, D
    KELSEN, D
    EISENBERGER, M
    HEELAN, R
    MAGILL, G
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (03) : 321 - 324
  • [24] CONTINUOUS 5-DAY INFUSION VINBLASTINE IN COMBINATION WITH PEPTICHEMIO IN THE TREATMENT OF REFRACTORY METASTATIC BREAST-CANCER
    YAP, HY
    BLUMENSCHEIN, GR
    BUZDAR, AU
    BODEY, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 156 - 156
  • [25] CONTINUOUS 5-DAY INFUSION OF VINBLASTINE FOR PERCUTANEOUS HEPATIC ARTERIAL CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
    FRASCHINI, G
    FLEISHMAN, G
    CHARNSANGAVEJ, C
    CARRASCO, CH
    HORTOBAGYI, GN
    CANCER TREATMENT REPORTS, 1987, 71 (11): : 1001 - 1005
  • [26] CONTINUOUS 5-DAY INFUSION OF PALA AND FU - BIOCHEMICALLY ORIENTED PHASE-I STUDY
    ARDALAN, B
    KLEIN, L
    BERTRAND, M
    PRESANT, C
    GREEN, L
    KOEHLER, S
    PULONE, B
    ROACH, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 190 - 190
  • [27] PHASE-I STUDY AND PHARMACOKINETICS OF CPT-11 WITH 5-DAY CONTINUOUS INFUSION
    OHE, Y
    SASAKI, Y
    SHINKAI, T
    EGUCHI, K
    TAMURA, T
    KOJIMA, A
    KUNIKANE, H
    OKAMOTO, H
    KARATO, A
    OHMATSU, H
    KANZAWA, F
    SAIJO, N
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (12) : 972 - 974
  • [28] A PHASE-I STUDY OF DOXIFLURIDINE AS A 5-DAY STEPPED-DOSE CONTINUOUS INFUSION
    OLVER, IN
    REECE, PA
    BISHOP, JF
    MORRIS, RG
    HILLCOAT, BL
    GUENTERT, TW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (04): : 308 - 311
  • [29] PHASE-II STUDY OF PROCARBAZINE (P) BY 5-DAY CONTINUOUS INFUSION (CI) IN PATIENTS (PTS) WITH METASTATIC NON-SMALL CELL LUNG-CANCER (NSCLC)
    MURPHY, WK
    UMSAWASDI, T
    DHINGRA, HM
    CHIUTEN, DF
    SPITZER, G
    CARR, DT
    NEIDHART, JA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 213 - 213
  • [30] PHASE-I TRIAL OF HOMOHARRINGTONINE ADMINISTERED AS A 5-DAY CONTINUOUS INFUSION
    COONLEY, CJ
    WARRELL, RP
    YOUNG, CW
    CANCER TREATMENT REPORTS, 1983, 67 (7-8): : 693 - 696
12345